Abstract
Background: Pancreatic cystic lesions (PCL) are common. They are increasingly detected as an incidental finding of transabdominal ultrasound or cross-sectional imaging. In contrast to other parenchymal organs, dysontogenetic pancreatic cysts are extremely rare. In symptomatic patients the most frequent PCL are acute and chronic pseudocysts. The majority of incidental cystic lesions, however, are neoplasias which have different risks of malignancy. Methods: PubMed was searched for studies, reviews, meta-analyses, and guidelines using the following key words: (‘pancreatic cystic lesions' OR ‘cystic pancreatic lesions' OR ‘intraductal papillary mucinous neoplasia' OR ‘mucinous cystic neoplasia' OR ‘pancreatic cyst' OR ‘pancreatic pseudocyst') AND (management OR treatment OR outcome OR prognosis OR diagnosis OR imaging OR ‘endoscopic ultrasound' EUS-FNA OR EUS OR ‘endoscopic ultrasonography' OR CT OR MRI). Retrieved papers were reviewed with regard to the diagnostic and therapeutic management of incidental PCL. Results: In addition to clinical criteria, transabdominal ultrasonography including contrast-enhanced ultrasonography, cross-sectional radiological imaging, and endoscopic ultrasound (EUS) are used for diagnostic characterization and risk assessment. EUS plays an outstanding role in differential diagnosis and prognostic characterization of incidental PCL. In a single examination it is possible to perform high-resolution morphological description, perfusion imaging, as well as fine-needle aspiration of cyst content, cyst wall, and solid components. An international consensus guideline has defined worrisome and high-risk criteria for the risk assessment of mucinous pancreatic cysts, which are mainly based on the results of EUS and cross-sectional imaging. Nevertheless, despite diagnostic progress and guideline recommendations, differential diagnosis and management decisions remain difficult. This review will discuss problems in and approaches to the diagnosis of incidental PCL. Conclusion: An evidence-based algorithm for the diagnosis of incidental PCL is proposed.
References
1.
Kimura W, Nagai H, Kuroda A, Muto T, Esaki Y: Analysis of small cystic lesions of the pancreas. Int J Pancreatol 1995;18:197-206.
2.
Kimura W: How many millimeters do atypical epithelia of the pancreas spread intraductally before beginning to infiltrate? Hepatogastroenterology 2003;50:2218-2224.
3.
Ishikawa T, Takeda K, Itoh M, et al: Prevalence of pancreatic cystic lesions including intraductal papillary mucinous neoplasms in patients with end-stage renal disease on hemodialysis. Pancreas 2009;38:175-179.
4.
de Jong K, Nio CY, Hermans JJ, et al: High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 2010;8:806-811.
5.
Lee KS, Sekhar A, Rofsky NM, Pedrosa I: Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 2010;105:2079-2084.
6.
Laffan TA, Horton KM, Klein AP, et al: Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 2008;191:802-807.
7.
Chernyak V, Flusberg M, Haramati LB, Rozenblit AM, Bellin E: Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality? Radiology 2015;274:161-169.
8.
Basturk O, Coban I, Adsay NV: Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med 2009;133:423-438.
9.
Kosmahl M, Pauser U, Peters K, Sipos B, Luttges J, Kremer B, Kloppel G: Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch 2004;445:168-178.
10.
Volkan Adsay N: Cystic lesions of the pancreas. Mod Pathol 2007;20(suppl 1):S71-93.
11.
Distler M, Kersting S, Niedergethmann M, et al: Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg 2013;258:324-330.
12.
Kloppel G, Basturk O, Schlitter AM, Konukiewitz B, Esposito I: Intraductal neoplasms of the pancreas. Semin Diagn Pathol 2014;31:452-466.
13.
Mino-Kenudson M, Fernandez-del Castillo C, Baba Y, et al: Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011;60:1712-1720.
14.
Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB: Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas 2008;36:50-55.
15.
Maire F, Hammel P, Terris B, et al: Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002;51:717-722.
16.
Ideno N, Ohtsuka T, Kono H, et al: Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg 2013;258:141-151.
17.
Uehara H, Nakaizumi A, Ishikawa O, et al: Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 2008;57:1561-1565.
18.
Tanno S, Nakano Y, Sugiyama Y, et al: Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology 2010;10:173-178.
19.
Yamaguchi K, Kanemitsu S, Hatori T, et al: Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 2011;40:571-580.
20.
Fritz S, Klauss M, Bergmann F, et al: Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg 2012;256:313-320.
21.
Gardner TB, Glass LM, Smith KD, et al: Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults. Am J Gastroenterol 2013;108:1546-1550.
22.
Kamata K, Kitano M, Kudo M, et al: Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Endoscopy 2014;46:22-29.
23.
Tada M, Kawabe T, Arizumi M, et al: Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol 2006;4:1265-1270.
24.
Sahani DV, Sainani NI, Blake MA, Crippa S, Mino-Kenudson M, Fernández-del Castillo C: Prospective evaluation of reader performance on MDCT in characterization of cystic pancreatic lesions and prediction of cyst biologic aggressiveness. AJR Am J Roentgenol 2011;197:W53-61.
25.
Lee HJ, Kim MJ, Choi JY, Hong HS, Kim KA: Relative accuracy of CT and MRI in the differentiation of benign from malignant pancreatic cystic lesions. Clin Radiol 2011;66:315-321.
26.
Sainani NI, Saokar A, Deshpande V, Fernandez-del Castillo C, Hahn P, Sahani DV: Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts. AJR Am J Roentgenol 2009;193:722-731.
27.
Waters JA, Schmidt CM, Pinchot JW, et al: CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 2008;12:101-109.
28.
Yu MH, Lee JY, Kim JH, Han JK, Choi BI: Value of near-isovoxel ultrasound for evaluation of ductal communications with pancreatic cystic lesions: correlation with magnetic resonance cholangiopancreatography. Ultrasound Med Biol 2013;39:2279-2284.
29.
Beyer-Enke SA, Hocke M, Ignee A, Braden B, Dietrich CF: Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance. JOP 2010;11:427-433.
30.
D'Onofrio M, Barbi E, Dietrich CF, et al: Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol 2012;81:630-638.
31.
D'Onofrio M, Megibow AJ, Faccioli N, Malago R, Capelli P, Falconi M, Mucelli RP: Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. AJR Am J Roentgenol 2007;189:1435-1442.
32.
Barresi L, Tarantino I, Granata A, Curcio G, Traina M: Pancreatic cystic lesions: how endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle. World J Gastrointest Endosc 2012;4:247-259.
33.
Jenssen C, Möller K: Schwierige endosonographische Differenzialdiagnosen am Pankreas - zystische Läsionen. Endo heute 2010;23:253-266.
34.
Schachschal G, Jenssen C: Pankreas: zystische Läsionen; in Jenssen C, Gottschalk U, Schachschal G, Dietrich CF (eds): Kursbuch Endosonografie. Stuttgart, Thieme, 2014, pp 223-240.
35.
Kim YC, Choi JY, Chung YE, Bang S, Kim MJ, Park MS, Kim KW: Comparison of MRI and endoscopic ultrasound in the characterization of pancreatic cystic lesions. AJR Am J Roentgenol 2010;195:947-952.
36.
Adimoolam V, Sanchez MJ, Siddiqui UD, Yu S, Dzuira JD, Padda MS, Aslanian HR: Endoscopic ultrasound identifies synchronous pancreas cystic lesions not seen on initial cross-sectional imaging. Pancreas 2011;40:1070-1072.
37.
Khashab MA, Kim K, Lennon AM, et al: Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms. Pancreas 2013;42:717-721.
38.
Hong SK, Loren DE, Rogart JN, et al: Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts. Gastrointest Endosc 2012;75:775-782.
39.
Rogart JN, Loren DE, Singu BS, Kowalski TE: Cyst wall puncture and aspiration during EUS-guided fine needle aspiration may increase the diagnostic yield of mucinous cysts of the pancreas. J Clin Gastroenterol 2011;45:164-169.
40.
Beane JD, House MG, Cote GA, et al: Outcomes after preoperative endoscopic ultrasonography and biopsy in patients undergoing distal pancreatectomy. Surgery 2011;150:844-853.
41.
Jenssen C, Alvarez-Sanchez MV, Napoleon B, Faiss S: Diagnostic endoscopic ultrasonography: assessment of safety and prevention of complications. World J Gastroenterol 2012;18:4659-4676.
42.
Tarantino I, Fabbri C, Di Mitri R, et al: Complications of endoscopic ultrasound fine needle aspiration on pancreatic cystic lesions: final results from a large prospective multicenter study. Dig Liver Dis 2014;46:41-44.
43.
Wang KX, Ben QW, Jin ZD, Du YQ, Zou DW, Liao Z, Li ZS: Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointest Endosc 2011;73:283-290.
44.
Yoon WJ, Daglilar ES, Fernandez-del Castillo C, Mino-Kenudson M, Pitman MB, Brugge WR: Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: the PIPE Study. Endoscopy 2014;46:382-387.
45.
Polkowski M, Larghi A, Weynand B, et al: Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline. Endoscopy 2012;44:190-206.
46.
Salvia R, Partelli S, Crippa S, et al: Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts. Am J Surg 2009;198:709-714.
47.
Fernandez-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL: Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003;138:427-433; discussion 433-434.
48.
Salvia R, Crippa S, Falconi M, Bassi C, Guarise A, Scarpa A, Pederzoli P: Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 2007;56:1086-1090.
49.
Hata T, Sakata N, Okada T, et al: Dilated papilla with mucin extrusion is a potential predictor of acute pancreatitis associated with intraductal papillary mucinous neoplasms of pancreas. Pancreatology 2013;13:615-620.
50.
Jang JW, Kim MH, Jeong SU, et al: Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis. J Gastroenterol Hepatol 2013;28:731-738.
51.
Pelletier AL, Hammel P, Rebours V, et al: Acute pancreatitis in patients operated on for intraductal papillary mucinous neoplasms of the pancreas: frequency, severity, and clinicopathologic correlations. Pancreas 2010;39:658-661.
52.
Ringold DA, Shroff P, Sikka SK, et al: Pancreatitis is frequent among patients with side-branch intraductal papillary mucinous neoplasia diagnosed by EUS. Gastrointest Endosc 2009;70:488-494.
53.
Manfredi R, Ventriglia A, Mantovani W, et al: Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization. Eur Radiol 2014;DOI: 10.1007/s00330-014-3493-2.
54.
Sahani DV, Kadavigere R, Saokar A, Fernandez-del Castillo C, Brugge WR, Hahn PF: Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 2005;25:1471-1484.
55.
Aso T, Ohtsuka T, Ideno N, et al: Diagnostic significance of a dilated orifice of the duodenal papilla in intraductal papillary mucinous neoplasm of the pancreas. Gastrointest Endosc 2012;76:313-320.
56.
Murakami Y, Uemura K, Ohge H, Hayashidani Y, Sudo T, Sueda T: Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Surgery 2006;140:448-453.
57.
Zhong N, Zhang L, Takahashi N, et al: Histologic and imaging features of mural nodules in mucinous pancreatic cysts. Clin Gastroenterol Hepatol 2012;10:192-198, 198.e191-192.
58.
Hocke M, Cui XW, Domagk D, Ignee A, Dietrich CF: Pancreatic cystic lesions: the value of contrast-enhanced endoscopic ultrasound to influence the clinical pathway. Endosc Ultrasound 2014;3:123-130.
59.
Yamashita Y, Ueda K, Itonaga M, et al: Usefulness of contrast-enhanced endoscopic sonography for discriminating mural nodules from mucous clots in intraductal papillary mucinous neoplasms: a single-center prospective study. J Ultrasound Med 2013;32:61-68.
60.
Ohno E, Itoh A, Kawashima H, et al: Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself. Pancreas 2012;41:855-862.
61.
Gonzalez Obeso E, Murphy E, Brugge W, Deshpande V: Pseudocyst of the pancreas: the role of cytology and special stains for mucin. Cancer 2009;117:101-107.
62.
Nasr J, Sanders M, Fasanella K, Khalid A, McGrath K: Lymphoepithelial cysts of the pancreas: an EUS case series. Gastrointest Endosc 2008;68:170-173.
63.
Leung KK, Ross WA, Evans D, Fleming J, Lin E, Tamm EP, Lee JH: Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. Ann Surg Oncol 2009;16:2818-2824.
64.
Oh HC, Kang H, Brugge WR: Cyst fluid amylase and CEA levels in the differential diagnosis of pancreatic cysts: a single-center experience with histologically proven cysts. Dig Dis Sci 2014;59:3111-3116.
65.
Cizginer S, Turner BG, Bilge AR, Karaca C, Pitman MB, Brugge WR: Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011;40:1024-1028.
66.
Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al: Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330-1336.
67.
Nagashio Y, Hijioka S, Mizuno N, et al: Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms. Pancreatology 2014;14:503-509.
68.
Thornton GD, McPhail MJ, Nayagam S, Hewitt MJ, Vlavianos P, Monahan KJ: Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis. Pancreatology 2013;13:48-57.
69.
Yoon WJ, Daglilar ES, Mino-Kenudson M, Morales-Oyarvide V, Pitman MB, Brugge WR: Characterization of epithelial subtypes of intraductal papillary mucinous neoplasm of the pancreas with endoscopic ultrasound and cyst fluid analysis. Endoscopy 2014;46:1071-1077.
70.
Al-Haddad M, DeWitt J, Sherman S, et al: Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts. Gastrointest Endosc 2014;79:79-87.
71.
Gillis A, Cipollone I, Cousins G, Conlon K: Does EUS-FNA molecular analysis carry additional value when compared to cytology in the diagnosis of pancreatic cystic neoplasm? A systematic review. HPB (Oxford) 2014;DOI: 10.1111/hpb.12364.
72.
Singhi AD, Nikiforova MN, Fasanella KE, et al: Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Clin Cancer Res 2014;20:4381-4389.
73.
Thosani N, Thosani S, Qiao W, Fleming JB, Bhutani MS, Guha S: Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis. Dig Dis Sci 2010;55:2756-2766.
74.
Suzuki R, Thosani N, Annangi S, Guha S, Bhutani MS: Diagnostic yield of EUS-FNA-based cytology distinguishing malignant and benign IPMNs: a systematic review and meta-analysis. Pancreatology 2014;14:380-384.
75.
Pitman MB, Michaels PJ, Deshpande V, Brugge WR, Bounds BC: Cytological and cyst fluid analysis of small (≤3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions. Pancreatology 2008;8:277-284.
76.
Pitman MB, Centeno BA, Daglilar ES, Brugge WR, Mino-Kenudson M: Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms. Cancer Cytopathol 2014;122:40-47.
77.
Morris-Stiff G, Lentz G, Chalikonda S, Johnson M, Biscotti C, Stevens T, Matthew Walsh R: Pancreatic cyst aspiration analysis for cystic neoplasms: mucin or carcinoembryonic antigen-which is better? Surgery 2010;148:638-644; discussion 644-635.
78.
Haab BB, Porter A, Yue T, Li L, Scheiman J, Anderson MA, Barnes D, et al: Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann Surg 2010;251:937-945.
79.
Distler M, Aust D, Weitz J, Pilarsky C, Grutzmann R: Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. Biomed Res Int 2014;2014:474905.
80.
Ji Y, Lou WH, Jin DY, Kuang TT, Zeng MS, Tan YS, Zeng HY, et al: A series of 64 cases of pancreatic cystic neoplasia from an institutional study of China. World J Gastroenterol 2006;12:7380-7387.
81.
Maker AV, Katabi N, Gonen M, DeMatteo RP, D'Angelica MI, Fong Y, Jarnagin WR, et al: Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol 2011;18:199-206.
82.
Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, et al: MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas. Pancreatology 2013;13:583-588.
83.
Correa-Gallego C, Ferrone CR, Thayer SP, Wargo JA, Warshaw AL, Fernandez-Del Castillo C: Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 2010;10:144-150.
84.
Cho CS, Russ AJ, Loeffler AG, Rettammel RJ, Oudheusden G, Winslow ER, Weber SM: Preoperative classification of pancreatic cystic neoplasms: the clinical significance of diagnostic inaccuracy. Ann Surg Oncol 2013;20:3112-3119.
85.
Fritz S, Klauss M, Bergmann F, Strobel O, Schneider L, Werner J, Hackert T, et al: Pancreatic Main-Duct Involvement in Branch-Duct IPMNs: An Underestimated Risk. Ann Surg 2014;260:848-856.
86.
de Jong K, van Hooft JE, Nio CY, Gouma DJ, Dijkgraaf MG, Bruno MJ, Fockens P: Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scand J Gastroenterol 2012;47:1056-1063.
87.
de Jong K, Nio CY, Mearadji B, Phoa SS, Engelbrecht MR, Dijkgraaf MG, Bruno MJ, et al: Disappointing interobserver agreement among radiologists for a classifying diagnosis of pancreatic cysts using magnetic resonance imaging. Pancreas 2012;41:278-282.
88.
Ahmad NA, Kochman ML, Brensinger C, Brugge WR, Faigel DO, Gress FG, Kimmey MB, et al: Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc 2003;58:59-64.
89.
de Jong K, Verlaan T, Dijkgraaf MG, Poley JW, van Dullemen H, Bruno MJ, Fockens P: Interobserver agreement for endosonography in the diagnosis of pancreatic cysts. Endoscopy 2011;43:579-584.
90.
Pitman MB, Centeno BA, Genevay M, Fonseca R, Mino-Kenudson M: Grading epithelial atypia in endoscopic ultrasound-guided fine-needle aspiration of intraductal papillary mucinous neoplasms: an international interobserver concordance study. Cancer Cytopathol 2013;121:729-736.
91.
Sigel CS, Edelweiss M, Tong LC, Magda J, Oen H, Sigel KM, Zakowski MF: Low interobserver agreement in cytology grading of mucinous pancreatic neoplasms. Cancer Cytopathol 2014;DOI: 10.1002/cncy.21492.
92.
Genevay M, Mino-Kenudson M, Yaeger K, et al: Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg 2011;254:977-983.
93.
Anand N, Sampath K, Wu BU: Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol 2013;11:913-921; quiz e59-60.
94.
Kim KW, Park SH, Pyo J, et al: Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg 2014;259:72-81.
95.
Park JW, Jang JY, Kang MJ, Kwon W, Chang YR, Kim SW: Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients? Pancreatology 2014;14:131-136.
96.
Crippa S, Salvia R, Warshaw AL, et al: Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 2008;247:571-579.
97.
Le Baleur Y, Couvelard A, Vullierme MP, et al: Mucinous cystic neoplasms of the pancreas: definition of preoperative imaging criteria for high-risk lesions. Pancreatology 2011;11:495-499.
98.
Arlix A, Bournet B, Otal P, et al: Long-term clinical and imaging follow-up of nonoperated branch duct form of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2012;41:295-301.
99.
Buscaglia JM, Giday SA, Kantsevoy SV, et al: Patient- and cyst-related factors for improved prediction of malignancy within cystic lesions of the pancreas. Pancreatology 2009;9:631-638.
100.
Das KK, Xiao H, Geng X, et al: mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN). Gut 2014;63:1626-1634.
101.
Kato Y, Takahashi S, Gotohda N, Konishi M: Risk factors for malignancy in branched-type intraductal papillary mucinous neoplasms of the pancreas during the follow-up period. World J Surg 2015;39:244-250.
102.
Jang JY, Park T, Lee S, et al: Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms. Br J Surg 2014;101:686-692.
103.
Kim YI, Woo SM, Lee WJ, et al: Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas. Scand J Gastroenterol 2013;48:610-616.
104.
Kobayashi N, Sugimori K, Shimamura T, et al: Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology 2012;12:141-145.
105.
Kobayashi G, Fujita N, Maguchi H, et al: Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study. Pancreas 2014;43:532-538.
106.
Koshita S, Fujita N, Noda Y, et al: Invasive carcinoma derived from ‘flat type' branch duct intraductal papillary mucinous neoplasms of the pancreas: impact of classification according to the height of mural nodule on endoscopic ultrasonography. J Hepatobiliary Pancreat Sci 2014;DOI: 10.1002/jhbp.199.
107.
Lee KH, Lee SJ, Lee JK, et al: Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm. Pancreas 2014;43:1306-1311.
108.
Maker AV, Katabi N, Qin LX, et al: Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res 2011;17:1502-1508.
109.
Nagai K, Doi R, Ito T, et al: Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2009;16:353-358.
110.
Ohno E, Hirooka Y, Itoh A, et al: Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg 2009;249:628-634.
111.
Roch AM, Parikh JA, Al-Haddad MA, et al: Abnormal serum pancreatic enzymes, but not pancreatitis, are associated with an increased risk of malignancy in patients with intraductal papillary mucinous neoplasms. Surgery 2014;156:923-929.
112.
Roch AM, Ceppa EP, DeWitt JM, Al-Haddad MA, House MG, Nakeeb A, Schmidt CM: International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative. HPB (Oxford) 2014;16:929-935.
113.
Sadakari Y, Ienaga J, Kobayashi K, et al: Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas 2010;39:232-236.
114.
Takuma K, Kamisawa T, Anjiki H, et al: Predictors of malignancy and natural history of main-duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2011;40:371-375.
115.
Tanaka M, Chari S, Adsay V, et al: International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
116.
Tanaka M, Fernandez-del Castillo C, Adsay V, et al: International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-197.
117.
Correa-Gallego C, Do R, Lafemina J, et al: Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol 2013;20:4348-4355.
118.
Lee CJ, Scheiman J, Anderson MA, et al: Risk of malignancy in resected cystic tumors of the pancreas ≤3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg 2008;12:234-242.
119.
Pelaez-Luna M, Chari ST, Smyrk TC, et al: Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 2007;102:1759-1764.
120.
Tang RS, Weinberg B, Dawson DW, et al: Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol 2008;6:815-819; quiz 719.
121.
Wu RI, Yoon WJ, Brugge WR, Mino-Kenudson M, Pitman MB: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) contributes to a triple-negative test in preoperative screening of pancreatic cysts. Cancer Cytopathol 2014;122:412-419.
122.
Das A, Ngamruengphong S, Nagendra S, Chak A: Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management. Gastrointest Endosc 2009;70:690-699.e6.
© 2015 S. Karger GmbH, Freiburg
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
